NCT00624065
Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
See it on ClinicalTrials.gov ↗432 people
44%
56%
190 womenmiddle line = equal numbers242 men
- Phase
- PHASE3
- Paid for by
- GlaxoSmithKline
- Finished
- 2008-08
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 54.1 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 76.2% · Black / African American 17.1% · Asian 5.1% · American Indian / Alaska Native 1.4% · More than one race 0.2%
Women left out
- No diabetes
Women with diabetes were turned away.
“Subject taking two or more antihypertensive medications, known contraindication to angiotensin-converting enzyme (ACE) inhibitors or alpha- or beta-blocker therapy, subject has Type 1 or Type 2 diabetes”
Study titles and rules are shown in their original English.